Webbsök sjukhusbiblioteken
 
Higher levels of the soluble receptor for advanced glycation end products and lower levels of the extracellular newly identified receptor for advanced glycation end products were associated with lipid-lowering drugs in patients with type 1 diabetes: a comparative cross-sectional study
Komihåglistan är tom
Vis
Författare/Namn
Titel
  • Higher levels of the soluble receptor for advanced glycation end products and lower levels of the extracellular newly identified receptor for advanced glycation end products were associated with lipid-lowering drugs in patients with type 1 diabetes: a comparative cross-sectional study
Utgivning
  • Lipids in Health and Disease (2020) 19:223 Open access BMC https://doi.org./10.1186s/12944-020-01397-2 2020
Serie
Ämne
Antal i kö:
  • 0 (0)
 
*000      ab
*00171389
*008       2020                        eng  
*100  $aMelin, Eva. O.
*245  $aHigher levels of the soluble receptor for advanced glycation end products and lower levels of the extracellular newly identified receptor for advanced glycation end products were associated with lipid-lowering drugs in patients with type 1 diabetes:$ba comparative cross-sectional study$cEva O. Melin
*260  $aOpen access BMC https://doi.org./10.1186s/12944-020-01397-2$bLipids in Health and Disease (2020) 19:223$c2020
*490  $aArtikel
*653  $aAtherosclerosis, Extracellular newly identified receptor for advanced glycation end products (EN-RAGE), Inflammation, Soluble receptor for advanced glycation and products (sRAGE), Type 1 diabetes
^
Det finns inga omdömen till denna titeln.
Klicka här för att vara den första som skriver ett omdöme.
Vis
Sänd till